Management of Tachyphylaxis with Ethylephrine in Hypotension

Introduction to Tachyphylaxis and Ethylephrine

The European Society of Cardiology recommends that ethylephrine should not be used for the chronic treatment of hypotension due to the lack of evidence of efficacy and the development of tachyphylaxis after 24-48 hours, and alternatives such as midodrine or non-pharmacological strategies should be considered 1

Tachyphylaxis is a well-documented phenomenon with vasoactive agents, particularly with nitrates, where it commonly occurs after 24-48 hours of continuous use, requiring progressive dose increments 2, 3

The clinical evidence does not support the use of ethylephrine for reflex syncope or chronic orthostatic hypotension, as a randomized double-blind controlled trial demonstrated that patients treated with ethylephrine 25 mg twice a day versus placebo did not show a difference in the frequency or time to recurrence of syncope 1

Midodrine is the preferred pharmacological alternative when long-term oral vasopressor treatment is required, and has demonstrated efficacy in small studies for symptomatic hypotension, although the evidence is limited 1
The dosing of midodrine requires frequent administration (typically three times a day), which can limit long-term compliance 1
Caution is advised in older men due to adverse effects on urinary flow 1
A "pill-in-the-pocket" strategy, where a single dose is administered 1 hour before activities that typically trigger symptoms, can be useful in selected patients instead of continuous chronic treatment 1

Non-pharmacological interventions should be the basis of treatment before considering any vasopressor, and physical counterpressure maneuvers (PCMs) have been shown to significantly reduce the burden of syncope (51% with conventional treatment vs 32% with PCMs, P < 0.005), with a 39% reduction in relative risk 1
Increasing salt and fluid intake to expand intravascular volume is recommended 1
Compression stockings can reduce venous pooling 1

For acute hypotension requiring immediate vasopressor support, ethylephrine is not the agent of choice, and norepinephrine is the first-line vasopressor for septic shock and severe hypotension, starting at 0.1-0.5 mcg/kg/min and titrating to achieve a mean arterial pressure ≥65 mmHg 4
Fluid resuscitation with crystalloids should precede or accompany the administration of vasopressors (minimum 30 mL/kg) 4
Central venous access is preferred for the administration of vasopressors to minimize the risk of extravasation 4

The European Society of Cardiology recommends that fludrocortisone, although widely used, lacks trial evidence to support its use in reflex syncope in adults 1
Beta-blockers should not be used for vasovagal syncope, as five out of six long-term follow-up studies demonstrated a lack of efficacy 1